Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kensey Nash Completes Sale to Spectranetics - Medical Product Outsourcing

Kensey Nash Completes Sale to Spectranetics

Deal valued at up to $24 million

Kensey Nash Corp. said Monday it has completed the sale of its endovascular business to Spectranetics Corp. in a deal valued at up to $24 million.

Spectranetics, of Colorado Springs, Colo., purchased Kensey Nash’s QuickCat and ThromCat blood clot removal devices and its SafeCross products, which are used to treat chronic total blockages.

The products generated sales of $5.1 million for Kensey Nash of Exton, Pa., last year.

As part of the sale, Kensey Nash will continue to manufacture and develop the products for Spectranetics for an initial term of three years.

The purchase price included an upfront payment of $10 million and additional payments of up to $14 million, based on future product sales and the development of “next generation” products that incorporate Kensey Nash’s technology.

SOURCE: Philadelphia Business Journal

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters